{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80767",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "N/A",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA",
      "recall_number": "D-1168-2018",
      "product_description": "Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle per box, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-718-10",
      "product_quantity": "8,574 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide",
      "recall_initiation_date": "20180808",
      "center_classification_date": "20180829",
      "termination_date": "20201103",
      "report_date": "20180905",
      "code_info": "Lot# 6K89A, 6K90A, 6K92A, exp 9/18"
    }
  ]
}